Amundi
IDXX icon

Amundi’s Idexx Laboratories IDXX Stock Holding History

Amundi’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$300M Sell
569,725
-41,054
-7% -$23M 0.07% 239
2026
Q1 		$343M Sell
610,779
-7,964
-1% -$5.11M 0.09% 200
2025
Q4 		$419M Buy
618,743
+26,144
+4% +$17.8M 0.11% 181
2025
Q3 		$372M Sell
592,599
-83,073
-12% -$50.4M 0.12% 147
2025
Q2 		$367M Sell
675,672
-47,439
-7% -$22.7M 0.13% 159
2025
Q1 		$297M Sell
723,111
-35,558
-5% -$15.4M 0.11% 192
2024
Q4 		$328M Buy
758,669
+56,837
+8% +$24.9M 0.11% 173
2024
Q3 		$334M Buy
701,832
+127,333
+22% +$61.9M 0.12% 169
2024
Q2 		$274M Sell
574,499
-175,505
-23% -$88.1M 0.11% 192
2024
Q1 		$358M Sell
750,004
-3,500
-0.5% -$1.91M 0.15% 147
2023
Q4 		$417M Buy
753,504
+141,439
+23% +$66.4M 0.19% 129
2023
Q3 		$261M Buy
612,065
+29,589
+5% +$14.8M 0.13% 187
2023
Q2 		$286M Buy
582,476
+84,540
+17% +$40.5M 0.14% 165
2023
Q1 		$237M Buy
497,936
+41,429
+9% +$19.8M 0.13% 179
2022
Q4 		$211M Buy
456,507
+52,514
+13% +$20.4M 0.12% 197
2022
Q3 		$141M Buy
403,993
+18,852
+5% +$6.93M 0.08% 266
2022
Q2 		$141M Buy
385,141
+69,177
+22% +$28.2M 0.11% 202
2022
Q1 		$174M Sell
315,964
-145,484
-32% -$76.5M 0.12% 198
2021
Q4 		$247M Buy
461,448
+64,757
+16% +$40.7M 0.16% 161
2021
Q3 		$247M Buy
396,691
+42,930
+12% +$28.8M 0.17% 144
2021
Q2 		$223M Buy
+353,761
New +$195M 0.16% 159

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Amundi's IDXX Position: Q2 2026 in Review

Amundi reduced its Idexx Laboratories (IDXX) stake by 6.7% in Q2 2026, selling an estimated $23M and leaving 569,725 shares worth $300M. The position accounts for 0.07% of the portfolio, ranked #239.

Amundi first reported a position in IDXX in Q2 2021 and has held it in 21 quarters since. The position peaked at $419M in Q4 2025. 1,302 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Amundi held 569,725 shares of Idexx Laboratories worth $300M as of Q2 2026.
  • Amundi sold 41,054 Idexx Laboratories shares in Q2 2026, an estimated $23M.
  • Idexx Laboratories made up 0.07% of Amundi's portfolio in Q2 2026, its #239 holding.
  • Amundi first reported a position in Idexx Laboratories in Q2 2021 and has held it in 21 quarters since.
  • Amundi's Idexx Laboratories position peaked at $419M in Q4 2025.
  • 1,302 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Amundi's 13F filing for Q2 2026, filed 11 Aug 2026.